Skip to main content

HSBC HOLDINGS PLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 873630 LONDON, X0

Position in TGTX

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$3,532,747
-$822,105 QoQ
Shares Held
106,344
-27.2% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Derivatives in TGTX

reported options exposure · as of Jun 30, 2025
CallValue
$1,230,858
CallShares
34,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $964,242,571 across 122 Biotechnology names. TGTX ranks #24 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TGTX

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,532,747 106,344
2025-12-31 $4,354,852 146,087
2025-09-30 $1,605,430 44,441
2025-06-30 $2,019,181 56,104
2025-06-30 $1,230,858 34,200
2025-03-31 $1,348,506 34,200
2025-03-31 $505,886 12,830
2024-12-31 $1,098,650 36,500
2024-12-31 $554,079 18,408
2024-09-30 $842,040 36,000
2024-09-30 $1,058,491 45,254
2024-06-30 $644,371 36,221
2024-06-30 $88,950 5,000
2024-06-30 $533,700 30,000
2024-03-31 $593,190 39,000
2024-03-31 $286,647 18,846
2023-12-31 $367,220 21,500
2023-12-31 $17,080 1,000
2023-06-30 $86,940 3,500
2023-06-30 $819,720 33,000
2023-03-31 $203,040 13,500
2022-03-31 $95,860 10,080
2022-03-31 $19,020 2,000
2021-09-30 $169,461 5,092
2021-09-30 $226,304 6,800
2021-06-30 $85,338 2,200
2021-06-30 $250,816 6,466
2021-03-31 $1,026,660 21,300
2021-03-31 $192,800 4,000
2020-12-31 $3,599,784 69,200
2020-09-30 $1,097,160 41,000
2020-09-30 $80,280 3,000
2020-06-30 $194,800 10,000
2020-06-30 $584,400 30,000